Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia.
Morley, N J
Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. [electronic resource] - Expert review of anticancer therapy 2016 - 159-64 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.2016.1131614 doi
Adult
Antibodies, Monoclonal, Humanized--adverse effects
Antineoplastic Agents--adverse effects
Apoptosis--drug effects
Humans
Inotuzumab Ozogamicin
Molecular Targeted Therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Randomized Controlled Trials as Topic
Recurrence
Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. [electronic resource] - Expert review of anticancer therapy 2016 - 159-64 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.2016.1131614 doi
Adult
Antibodies, Monoclonal, Humanized--adverse effects
Antineoplastic Agents--adverse effects
Apoptosis--drug effects
Humans
Inotuzumab Ozogamicin
Molecular Targeted Therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Randomized Controlled Trials as Topic
Recurrence